Delivery Order SPE2DB22D1103-SPE2DB25FTKE5

Award Date 4/11/25
Potential Completion Date 4/14/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,455.63, is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of January 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,320.33, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,310.40 firm fixed-price contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has a performance period extending through May 21, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2 gm, a pharmaceutical product, at a ceiling value of $1,755.12. The contract is a firm fixed-price delivery order with a completion date of June 22, 2023. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,203.97. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,310.40 firm fixed-price delivery order contract is for the supply of the pharmaceutical product Budesonide-Formoterol 160-4.5 10.2GM. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4,565,952,996 units of a pharmaceutical product, Budesonide-Formoterol 160-4.5 10.2 GM. The contract has a firm fixed price of $1,196.04 and a completion date of September 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of its broader indefinite delivery contract (IDC) with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Budesonide-Formoterol 160-4.5 10.2GM medication. The contract has a Firm Fixed Price pricing type, a ceiling value of $1,515.72, and an ultimate completion date of October 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,522.36. The contract is a firm fixed-price, non-set-aside delivery order with a performance period ending on May 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,210.56, is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a respiratory medication, with a final delivery date of December 12, 2023. The contract is structured as a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen also holds a larger Indefinite...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTKE5
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,814.64, is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 14, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated as a set-aside contract.

Generated 7/11/25, 9:45 AM